Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Ps Multiple | 0.4x - 0.5x | 0.4x |
| Selected Fwd Ps Multiple | 0.4x - 0.4x | 0.4x |
| Fair Value | €1.08 - €1.20 | €1.14 |
| Upside | 8.4% - 19.8% | 14.1% |
| Benchmarks | Ticker | Full Ticker |
|---|---|---|
| Biosynex SA | - | ENXTPA:ALBIO |
| Laboratoires Euromedis Société anonyme | - | ENXTPA:ALEMG |
| Crossject Société Anonyme | - | ENXTPA:ALCJ |
| Theraclion SA | - | ENXTPA:ALTHE |
| Implanet S.A. | - | ENXTPA:ALIMP |
| Diagnostic Medical Systems S.A. | - | ENXTPA:ALDMS |
| Select Price / LTM Sales Ratio | ||||||||
| Benchmark Companies | ||||||||
| ALBIO | ALEMG | ALCJ | ALTHE | ALIMP | ALDMS | |||
| ENXTPA:ALBIO | ENXTPA:ALEMG | ENXTPA:ALCJ | ENXTPA:ALTHE | ENXTPA:ALIMP | ENXTPA:ALDMS | |||
| Historical Sales Growth | ||||||||
| 5Y CAGR | 24.3% | -13.2% | -3.4% | -1.2% | 2.1% | 9.8% | ||
| 3Y CAGR | -15.5% | -42.2% | -14.0% | 34.8% | 24.1% | 8.0% | ||
| Latest Twelve Months | 7.3% | -37.4% | 6.3% | -31.4% | 26.3% | 16.7% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 2.4% | 7.2% | -207.4% | -294.2% | -64.0% | -14.3% | ||
| Prior Fiscal Year | 8.0% | -10.9% | -223.1% | -401.8% | -44.1% | -12.2% | ||
| Latest Fiscal Year | -39.7% | 35.0% | -310.9% | -201.7% | -89.6% | -22.1% | ||
| Latest Twelve Months | -37.0% | 58.5% | -310.9% | -277.7% | -94.7% | -32.2% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | -4.2x | -4.3x | -9.4x | -2.8x | -4.9x | -22.1x | ||
| Price / LTM Sales | 0.3x | 0.4x | 15.2x | 6.5x | 1.4x | 0.4x | ||
| LTM P/E Ratio | -0.8x | 0.6x | -4.9x | -2.3x | -2.4x | -1.2x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/S Ratio | 0.3x | 1.4x | 15.2x | |||||
| Historical LTM P/S Ratio | 0.6x | 0.7x | 0.8x | |||||
| Selected Price / Sales Multiple | 0.4x | 0.4x | 0.5x | |||||
| (x) LTM Sales | 47 | 47 | 47 | |||||
| (=) Equity Value | 19 | 20 | 21 | |||||
| (/) Shares Outstanding | 18.1 | 18.1 | 18.1 | |||||
| Implied Value Range | 1.05 | 1.10 | 1.16 | |||||
| FX Rate: EUR/EUR | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 1.05 | 1.10 | 1.16 | 1.00 | ||||
| Upside / (Downside) | 5.1% | 10.6% | 16.2% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | ALBIO | ALEMG | ALCJ | ALTHE | ALIMP | ALDMS | |
| Value of Common Equity | 33 | 11 | 63 | 8 | 13 | 18 | |
| (/) Shares Outstanding | 18.7 | 2.8 | 47.8 | 46.3 | 125.0 | 18.1 | |
| Implied Stock Price | 1.74 | 3.96 | 1.31 | 0.18 | 0.10 | 1.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 1.74 | 3.96 | 1.31 | 0.18 | 0.10 | 1.00 | |
| Trading Currency | EUR | EUR | EUR | EUR | EUR | EUR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |